Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research
Hera Biolabs, the University of Michigan, Case Western Reverse University [...]
The OncoRat®: Hosting valuable tumor xenograft models that are difficult or impossible to study using in vitro or mouse models
One of the most widely used methods of modeling human [...]
Patient derived xenograft studies from wider varieties of patient sub-populations promise improved clinical trial selection and design
Around 85% of preclinical drugs entering clinical trials in oncology [...]
OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars
While advances in in-vitro platforms have allowed researchers to better [...]
Hera Biolabs to present at the 2018 AACR Annual Meeting.
Hera Biolabs will be presenting xenograft, PDX, and humanization of [...]
Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice
Pharmaceutical researchers and regulators are increasingly aware of the influence [...]
Using Patient Derived Xenografts to Improve Therapeutic Cancer Treatments
An increased understanding of human tumors has created a solid [...]
Humanized immune-system SRG Rats™ & mice for immuno-oncology
The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]
Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes
A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]
Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes
A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]
Using Cell Sheet Technique to Study the Development of HCC in Rat Models
As the single most prevalent primary liver cancer and the [...]
Understanding Circadian Rhythms in Humanized Mice
The human body’s circadian rhythm can significantly impact many biological [...]
Humanized Mice as Preclinical Models for Liver Stage Malaria Infection
Malaria continues to affect 250 million people around the world [...]
HIS Mice Provide New Preclinical Model for Human Skin Immunity
Despite the convenience and appeal of oral therapies, the reality [...]
What’s Old is New Again: Chemical Carcinogenesis Models of Cancer
Early cancer research focused primarily on chemical carcinogenesis in rat [...]
Hera Presents at SOT 2017 & AACR 2017 Recap
Hera strives to provide its clients with superior preclinical toxicology [...]
Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions
Humanized liver mouse models are increasingly being used in preclinical [...]
Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL
First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]
PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors
Despite ongoing research, lung cancers have remained among the most [...]
Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus
Hepatitis E virus (HEV) is estimated to cause more than [...]
Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant
Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]
Transgenic Rats as Research Models Boast Significant Benefits….
Transgenic Rats as Research Models Boast Significant Benefits over Mouse [...]
Humanized Mouse Xenograft Models: The Best of Both Worlds
Xenograft rodent models and cultured cells have long been used [...]
Xenograft Rat Models Give Hope to New Therapeutic Treatments for Leukemia
Mutations in DNA methyltransferase 3A (DNMT3A) are common in acute [...]
Hera BioLabs in Genetic Engineering News
Hera BioLabs and our VP of Research and Development Tseten [...]
Advancements in Stem Cell-Based Therapies for Malignant Brain Tumors
Despite many great developments in the overall treatment of cancers, [...]
Hera BioLabs Receives PHS Approved Animal Welfare Assurance
Hera BioLabs, Inc. (Lexington KY) announced today that it has [...]
Humanized Rodent Models: A Critical Research Tool
Chimeric humanized liver rodent models are being used by those [...]
Lexington based toxicology lab, Hera BioLabs, partners with the NIH to use firefly proteins for drug discovery research
Hera BioLabs, a Lexington based contract research organization (CRO), announced [...]
Hera BioLabs, Inc. licenses SH-SY5Y neuroblastoma cell line and introduced neurotoxicity services
Lexington, KY - February 25, 2016 – Hera BioLabs, Inc. [...]
Hera to exhibit and present at the 2016 SOT ToxExpo
Hera will be located at booth 1103 of the SOT [...]
Hera presents at the 2015 American College of Toxicology
Hera to present at the 2015 American College of Toxicology [...]